- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01435707
The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids
December 24, 2013 updated by: Woo Seog Sim, Samsung Medical Center
There has been no reports of the effect of various kinds of steroid or various dose of steroid which are commonly used in the clinical setting.
Previous studies have simply shown that the blood glucose level is elevated in diabetes patients and did not show or suggest the adequate strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or injection interval.
Therefore, the investigators tried to evaluate the effect of different dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on the blood glucose level.
Study Overview
Status
Completed
Conditions
Detailed Description
It is well known that blood glucose level is elevated in diabetes patients more than non-diabetes patients who underwent the epidural steroid injection.
However, there has been no reports of the effect of various kinds of steroid or various dose of steroid which are commonly used in the clinical setting.
Previous studies have simply shown that the blood glucose level is elevated in diabetes patients and did not show or suggest the adequate strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or injection interval.
Therefore, the investigators tried to evaluate the effect of different dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on the blood glucose level.
Study Type
Interventional
Enrollment (Actual)
125
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 135-710
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- subjects who undergo epidural steroid injection (caudal epidural injection or selective transforaminal block) in the pain medicine outpatient clinic
- subjects older than 20 yrs.
Exclusion Criteria:
- ASA (American society of Anesthesiologists class) III or more
- severe cardiopulmonary disease or brain disorder
- Subjects diagnosed uncontrolled diabetes with complications
- subjects undergoing hormone therapy
- subjects with active infection
- subjects with pregnancy
- subjects with recent stress condition such as surgery or trauma
- subjects with active neurologic disorder
- those with anticoagulation therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Caudal 40 group
subjects who undergo caudal epidural block with triamcinolone 40 mg
|
epidural steroid injection with Triamcinolone 40mg
Other Names:
|
|
Experimental: STE 20 group
subjects who undergo selective transforaminal block with triamcinolone 20 mg
|
Selective transforaminal epidural block with triamcinolone 20 mg
Other Names:
|
|
Experimental: Caudal 20 mg
subjects who undergo caudal epidural block with triamcinolone 20 mg
|
caudal epidural steroid injection with Triamcinolone 20mg
Other Names:
|
|
Experimental: STE 40 group
subjects who undergo selective transforaminal block with triamcinolone 40 mg
|
Selective transforaminal epidural block with triamcinolone 40 mg
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 1
|
before breakfast (fasting state)
|
at 7:00 am of postprocedure day 1
|
|
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 2
|
before breakfast (fasting state)
|
at 7:00 am of postprocedure day 2
|
|
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 3
|
at 7:00 am of postprocedure day 3
|
|
|
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 4
|
at 7:00 am of postprocedure day 4
|
|
|
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 5
|
at 7:00 am of postprocedure day 5
|
|
|
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 6
|
at 7:00 am of postprocedure day 6
|
|
|
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 7
|
at 7:00 am of postprocedure day 7
|
|
|
fasting blood glucose
Time Frame: at 7:00 am of postprocedure day 14
|
at 7:00 am of postprocedure day 14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
post-prandial glucose level
Time Frame: 2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 14
|
2 hour after dinner
|
2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 14
|
|
visual analogue scale of subjective pain
Time Frame: at 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14
|
at 7:00 am of postprocedure day 5
|
at 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
September 15, 2011
First Submitted That Met QC Criteria
September 16, 2011
First Posted (Estimate)
September 19, 2011
Study Record Updates
Last Update Posted (Estimate)
December 25, 2013
Last Update Submitted That Met QC Criteria
December 24, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Back Pain
- Low Back Pain
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Anti-Inflammatory Agents
- Immunosuppressive Agents
- Immunologic Factors
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Triamcinolone
- Triamcinolone Acetonide
- Triamcinolone hexacetonide
- Triamcinolone diacetate
Other Study ID Numbers
- 2011-08-058
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
University of Kansas Medical CenterCompletedLower Back Pain | Low Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, Postural | Postural Low Back Pain | Mechanical Low Back Pain | Low Back Ache | Recurrent Low Back Pain | Lower Back Pain Chronic | Low Back Pain, Posterior Compartment | Low BackacheUnited States
-
Istanbul UniversityIstinye UniversityCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, PosturalTurkey
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
General Incorporated Foundation Ryukyuseimeisaiseikai...CompletedChronic Low Back Pain | Non-specific Low Back Pain | Low Back Pain (LBP)Japan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
Clinical Trials on epidural steroid injection with Triamcinolone 40mg
-
Dallas VA Medical CenterUniversity of Texas Southwestern Medical CenterCompleted
-
Istanbul Medeniyet UniversityMarmara UniversityRecruitingLumbosacral RadiculopathyTurkey
-
Franklin Pierce UniversityUniversity of Colorado, DenverCompletedLumbar Spinal StenosisUnited States
-
Yakov Perper, MDCompletedNeck Pain | Cervical Radiculopathy | Disc Prolapse With RadiculopathyUnited States
-
Clinique du Sport, Bordeaux MérignacRecruiting
-
Seoul National University Bundang HospitalCompleted
-
Aydin Adnan Menderes UniversityActive, not recruitingDorsal Root Ganglion Stimulation | Transforaminal Epidural Injection | Servical Disc HerniationTurkey (Türkiye)
-
Marmara UniversityNot yet recruitingSciatica | Lumbar Disc Herniation | Lumbar Radiculopathy | Radicular Low Back PainTurkey (Türkiye)
-
Marmara UniversityRecruitingFibromyalgia | Herniated Disk LumbarTurkey
-
Marmara UniversityCompletedMetabolic Syndrome | Herniated Disk LumbarTurkey (Türkiye)